Purpose: To evaluate the long-term outcome of the Molteno implant drai
nage device using survival analysis. Methods: A retrospective chart re
view was performed on 77 eyes of 71 patients that underwent Molteno im
plantation for intractable glaucoma unresponsive to conventional manag
ement from October 1984 to April 1990 at the University of Washington
Eye Center and had at least 6 months of follow-up data. Success was de
fined as a postoperative intraocular pressure of 22 mmHg or lower with
(qualified success) or without (complete success) glaucoma medication
s and no additional glaucoma surgery, phthisis, or loss of light perce
ption. Results: The median follow-up was 44 months (range, 6-107 month
s). Indications for Molteno implantation were aphakia/pseudophakia (n
= 24), neovascular glaucoma (n = 20), uveitic glaucoma (n = 12), faile
d trabeculectomy (n = 9), traumatic glaucoma (n = 8), and congenital g
laucoma (n = 4). The total success was 57% (23% complete; 34% qualifie
d) at the last follow-up. Kaplan-Meier survival curves demonstrated a
continuous and relatively linear attrition of success over at least 5
1/2 postoperative years, The uveitic glaucoma group had the highest su
ccess rate of 75%. Eyes with neovascular glaucoma failed significantly
more frequently than those with uveitic glaucoma (P < 0.01). There wa
s no significant difference in outcome based on sex, race, single vers
us double plate, anterior chamber versus posterior chamber tube placem
ent, or two-stage versus single-stage surgery, Younger age was associa
ted with a significantly higher failure rate after controlling for gla
ucoma category (P < 0.01). Conclusion: The Molteno implant drainage de
vice offers a reasonable long-term outcome in eyes with intractable gl
aucomas. However, an ongoing rate of failure, not unlike that seen aft
er other filtration surgery, is to be expected.